Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Agios Pharmaceuticals Inc (AGIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15100
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 enzyme used for the treatment of patients with R/R acute myeloid leukemia (AML); and TIBSOVO (ivosidenib), a prescription medicine used to treat adults with AML. Its pipeline products include AG-881, a pan-IDH mutant inhibitor intended for the treatment of hematologic malignancies and solid tumors; AG-270, an inhibitor of methionine adenosyltransferase 2a; and Mitapivat, a potent activator intended for the treatment of patients with pyruvate kinase deficiency. Agios is headquartered in Cambridge, Massachusetts, the US.

Agios Pharmaceuticals Inc Key Recent Developments

Feb 25,2019: Agios Reports Updated Data from Phase 1 Study of Ivosidenib in Combination with Azacitidine Demonstrating Deep and Durable Responses in Newly Diagnosed IDH1 Mutant Acute Myeloid Leukemia (AML) Patients
Feb 14,2019: Agios reports fourth quarter and full year 2018 financial results
Nov 01,2018: Agios reports third quarter 2018 financial results
Sep 05,2018: 2018 Veeva R&D summit to showcase advances for speeding product development
Sep 04,2018: Agios Announces Chief Executive Officer Succession Plan

This comprehensive SWOT profile of Agios Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Agios Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Agios Pharmaceuticals Inc – Key Information
Agios Pharmaceuticals Inc – Overview
Agios Pharmaceuticals Inc – Key Employees
Agios Pharmaceuticals Inc – Key Employee Biographies
Agios Pharmaceuticals Inc – Key Operational Heads
Agios Pharmaceuticals Inc – Major Products and Services
Agios Pharmaceuticals Inc – History
Agios Pharmaceuticals Inc – Company Statement
Agios Pharmaceuticals Inc – Locations And Subsidiaries
Agios Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Agios Pharmaceuticals Inc – Business Description
Agios Pharmaceuticals Inc – Corporate Strategy
Agios Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Agios Pharmaceuticals Inc – Strengths
Agios Pharmaceuticals Inc – Weaknesses
Agios Pharmaceuticals Inc – Opportunities
Agios Pharmaceuticals Inc – Threats
Agios Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Agios Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Agios Pharmaceuticals Inc, Key Information
Agios Pharmaceuticals Inc, Key Ratios
Agios Pharmaceuticals Inc, Share Data
Agios Pharmaceuticals Inc, Major Products and Services
Agios Pharmaceuticals Inc, History
Agios Pharmaceuticals Inc, Key Employees
Agios Pharmaceuticals Inc, Key Employee Biographies
Agios Pharmaceuticals Inc, Key Operational Heads
Agios Pharmaceuticals Inc, Other Locations
Agios Pharmaceuticals Inc, Subsidiaries
Agios Pharmaceuticals Inc, Key Manufacturing facilities
Agios Pharmaceuticals Inc, Key Competitors
Agios Pharmaceuticals Inc, SWOT Analysis
Agios Pharmaceuticals Inc, Ratios based on current share price
Agios Pharmaceuticals Inc, Annual Ratios
Agios Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Agios Pharmaceuticals Inc, Performance Chart
Agios Pharmaceuticals Inc, Ratio Charts

★海外企業調査レポート[Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Software AG (SOW):企業の財務・戦略的SWOT分析
    Summary Software AG (SAG) is a technology company that provides software management solutions. The company offers digital business platform with integration, process management, adaptive application development, real-time analytics and enterprise architecture management. Its products include Adabas …
  • Roka Bioscience Inc:医療機器:M&Aディール及び事業提携情報
    Summary Roka Bioscience Inc (Roka) is a manufacturer and distributor of molecular assays and instruments for food safety industry. The company offers products such as Atlas- automated molecular pathogen detection system, the listeria LSP detection assay, listeria monocytogenes Lmg2 detection assay, …
  • TerniEnergia SpA (TER):電力:M&Aディール及び事業提携情報
    Summary TerniEnergia SpA (TerniEnergia), a subsidiary of Terni Research SpA is a renewable energy company that offers energy efficiency, renewable energy, waste, and energy management solutions. The company offers environmental and waste to energy, recovery of materials and development and productio …
  • Kforce Inc. (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc. (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • PT Hexindo Adiperkasa Tbk:企業の戦略・SWOT・財務情報
    PT Hexindo Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Hexindo Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • XBiotech Inc (XBIT):製薬・医療:M&Aディール及び事業提携情報
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Determine Inc (DTRM):企業の財務・戦略的SWOT分析
    Summary Determine Inc (Determine), formerly Selectica Inc and a subsidiary of Corcentric, is a technology company. The company provides SaaS source-to-pay and enterprise contract lifecycle management solutions. It offers solutions such as strategic sourcing, supplier management; procure to pay, invo …
  • Air Lease Corporation:企業の戦略・SWOT・財務情報
    Air Lease Corporation - Strategy, SWOT and Corporate Finance Report Summary Air Lease Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • 3SBio Inc (1530):製薬・医療:M&Aディール及び事業提携情報
    Summary 3SBio Inc (3SBio) is a biotechnology companies that carries out the research, development, manufacturing and marketing of biopharmaceutical products. It develops recombinant, or genetically engineered, protein-based products and other pharmaceutical product candidates to address large market …
  • Central National Gottesman Inc:企業の戦略・SWOT・財務分析
    Central National Gottesman Inc - Strategy, SWOT and Corporate Finance Report Summary Central National Gottesman Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Isarna Therapeutics GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Isarna Therapeutics GmbH (Isarna), formerly Antisense Pharma GmbH is a healthcare products provider that develops products for ophthalmic, fibrotic diseases and cancers. The company offers antisense technology based drugs that treats aggressive tumor diseases. Its product include TGF-ß, a in …
  • NanoRepro AG (NN6):製薬・医療:M&Aディール及び事業提携情報
    Summary NanoRepro AG (NanoRepro) is a manufacturer of fast-diagnostics and nutritional food supplements for home and clinical use. The company offers wide range of rapid diagnostic tests products in the areas of family planning, disease detection (preventive healthcare), food intolerances, allergies …
  • Nintendo Co., Ltd.:企業の戦略・SWOT・財務分析
    Nintendo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nintendo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bechtel Corporation:電力:M&Aディール及び事業提携情報
    Summary Bechtel Corporation (Bechtel) is a provider of engineering, construction and project management services. It provides a diverse portfolio of services to energy, transportation, infrastructure, communications, mining and metals, oil and gas, chemicals, water, defense and nuclear, and governme …
  • Jamaica Public Service Co Ltd:企業の戦略的SWOT分析
    Jamaica Public Service Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • OcuNexus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OcuNexus Therapeutics Inc (OcuNexus Therapeutics) is a development stage biopharmaceutical company engaged in novel therapeutics for unmet clinical needs in ophthalmology. It has highly differentiated, lead drug candidates based upon a novel mechanism of action such as Gap Junction Channel M …
  • Jardine Matheson Holdings Ltd:企業の戦略・SWOT・財務分析
    Jardine Matheson Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Jardine Matheson Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Hafslund ASA:企業の戦略的SWOT分析
    Hafslund ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • S&T Bancorp Inc:企業の戦略・SWOT・財務情報
    S&T Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary S&T Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆